|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,230.00 INR | -0.17% |
|
+1.73% | +9.57% |
| 03/08 | Glenmark Pharmaceuticals Limited, Q1 2027 Earnings Call, Aug 03, 2026 | |
| 31/07 | India's Glenmark Pharma posts higher quarterly profit on strong demand | RE |
| Market Cap | 63TCr 660.23Cr 573.81Cr 535.71Cr 491.79Cr 927.31Cr 943.47Cr 6.32TCr 2.47TCr 31TCr 2.48TCr 2.43TCr 1,03500Cr | P/E 2026 |
44.2x | P/E 2027 * | 27.1x |
|---|---|---|---|---|---|
| Enterprise Value | 59TCr 619.01Cr 537.98Cr 502.26Cr 461.09Cr 869.41Cr 884.56Cr 5.92TCr 2.32TCr 29TCr 2.33TCr 2.27TCr 97TCr | EV / Sales 2026 |
3.51x | EV / Sales 2027 * | 3.4x |
| Free-Float |
51.04% | Yield 2026 |
0.12% | Yield 2027 * | 0.17% |
Last Transcript: Glenmark Pharmaceuticals Limited
| 1 day | -0.17% | ||
| 1 week | +1.73% | ||
| Current month | -0.17% | ||
| 1 month | +1.55% | ||
| 3 months | -7.33% | ||
| 6 months | +16.12% | ||
| Current year | +9.57% |
| 1 week | 2,162 |  | 2,270.2 |
| 1 month | 2,162 | | 2,326.1 |
| Current year | 1,842 | | 2,474 |
| 1 year | 1,792.6 | | 2,474 |
| 3 years | 722.1 | | 2,474 |
| 5 years | 348.5 | | 2,474 |
| 10 years | 161.65 | | 2,474 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/01/2000 | |
Anurag Mantri
DFI | Director of Finance/CFO | 54 | 27/05/2025 |
Indrajit Bose
PSD | President | - | 15/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Cherylann Pinto
BRD | Director/Board Member | 58 | - |
| Chairman | 56 | 12/05/2011 | |
| Director/Board Member | 85 | 14/08/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.17% | +1.73% | +7.84% | +185.66% | 660.39Cr | |
| -1.36% | +1.15% | +20.48% | +72.96% | 5TCr | |
| +3.60% | +3.09% | +54.20% | +116.82% | 3.66TCr | |
| +0.08% | +4.52% | -1.89% | +26.20% | 1.25TCr | |
| -0.51% | +1.11% | +18.12% | +78.33% | 1.18TCr | |
| -1.33% | -0.76% | +30.73% | +130.67% | 903.81Cr | |
| -1.95% | -4.00% | +42.44% | -12.71% | 702.99Cr | |
| +1.10% | +2.58% | +14.71% | +34.12% | 679.37Cr | |
| -0.24% | +3.14% | -35.41% | +8.71% | 549.26Cr | |
| +1.41% | +4.29% | +30.38% | +108.66% | 453.34Cr | |
| Average | +0.06% | +1.26% | +18.16% | +74.94% | 1.5TCr | |
| Weighted average by Cap. | +0.30% | +1.36% | +25.73% | +81.56% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 15TCr 160.64Cr 139.61Cr 130.34Cr 119.65Cr 225.62Cr 229.55Cr 1.54TCr 601.92Cr 7.64TCr 603.38Cr 590.02Cr 25TCr | 17TCr 176.26Cr 153.19Cr 143.02Cr 131.29Cr 247.56Cr 251.88Cr 1.69TCr 660.47Cr 8.38TCr 662.07Cr 647.41Cr 28TCr |
| Net income | 2.05TCr 22Cr 19Cr 17Cr 16Cr 30Cr 31Cr 206.09Cr 81Cr 1.02TCr 81Cr 79Cr 3.38TCr | 2.31TCr 24Cr 21Cr 20Cr 18Cr 34Cr 35Cr 231.92Cr 91Cr 1.15TCr 91Cr 89Cr 3.8TCr |
| Net Debt | -3.93TCr -41Cr -36Cr -33Cr -31Cr -58Cr -59Cr -394.42Cr -154.47Cr -1.96TCr -154.85Cr -151.42Cr -6.46TCr | -5.85TCr -61Cr -53Cr -50Cr -46Cr -86Cr -88Cr -587.28Cr -230.01Cr -2.92TCr -230.57Cr -225.46Cr -9.62TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/26/03 | ₹2,230.00 | -0.17% | 13,07,223 |
| 31/26/31 | ₹2,233.90 | +1.99% | 3,71,153 |
| 30/26/30 | ₹2,190.30 | -3.16% | 4,51,791 |
| 29/26/29 | ₹2,261.70 | +3.53% | 5,93,720 |
| 28/26/28 | ₹2,184.60 | -0.52% | 4,90,034 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
Select your edition
All financial news and data tailored to specific country editions
